Xiaoling Luo

1.4k total citations
43 papers, 925 citations indexed

About

Xiaoling Luo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Xiaoling Luo has authored 43 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 12 papers in Immunology and 11 papers in Oncology. Recurrent topics in Xiaoling Luo's work include Epigenetics and DNA Methylation (5 papers), Immune Cell Function and Interaction (5 papers) and MicroRNA in disease regulation (4 papers). Xiaoling Luo is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Immune Cell Function and Interaction (5 papers) and MicroRNA in disease regulation (4 papers). Xiaoling Luo collaborates with scholars based in China, United States and Canada. Xiaoling Luo's co-authors include Ke Cui, M.R. Ven Murthy, Keyi Xu, Jeffrey Schlom, Karin M. Knudson, Jin‐Qiu Chen, Kristin C. Hicks, Sofia R. Gameiro, Rong Liang and Siyu Liu and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Xiaoling Luo

39 papers receiving 899 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaoling Luo China	15	411	250	143	142	72	43	925
Hana Jin South Korea	21	512 1.2×	189 0.8×	155 1.1×	134 0.9×	56 0.8×	33	964
Siamak Salami Iran	19	557 1.4×	188 0.8×	104 0.7×	176 1.2×	86 1.2×	63	1.1k
Sarmistha Banerjee United States	12	627 1.5×	206 0.8×	92 0.6×	198 1.4×	71 1.0×	27	1.1k
Bedia Çakmakoğlu Türkiye	19	480 1.2×	210 0.8×	152 1.1×	111 0.8×	38 0.5×	76	961
Weiwei Tao China	20	555 1.4×	136 0.5×	179 1.3×	144 1.0×	52 0.7×	37	1.1k
Yuxin Li China	22	643 1.6×	151 0.6×	143 1.0×	163 1.1×	52 0.7×	68	1.2k
Xueting Deng China	14	447 1.1×	174 0.7×	110 0.8×	196 1.4×	79 1.1×	28	1.1k
Nina Xue China	18	508 1.2×	143 0.6×	154 1.1×	94 0.7×	51 0.7×	46	896
Joon‐Suk Park South Korea	17	337 0.8×	161 0.6×	89 0.6×	91 0.6×	101 1.4×	45	786

Countries citing papers authored by Xiaoling Luo

Since Specialization

Citations

This map shows the geographic impact of Xiaoling Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Luo more than expected).

Fields of papers citing papers by Xiaoling Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoling Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Luo. The network helps show where Xiaoling Luo may publish in the future.

Co-authorship network of co-authors of Xiaoling Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoling Luo. A scholar is included among the top collaborators of Xiaoling Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoling Luo. Xiaoling Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Xiaoguang, Qin-Kun Li, Xiao‐Tian Liang, et al.. (2025). Comprehensive Evaluation and Screening of Autumn-Sown Oat (Avena sativa L.) Germplasm in Different Agropastoral Regions. Agronomy. 15(4). 994–994.

Chen, Meifeng, et al.. (2025). Donafenib activates the p53 signaling pathway in hepatocellular carcinoma, induces ferroptosis, and enhances cell apoptosis. Clinical and Experimental Medicine. 25(1). 29–29. 4 indexed citations

Luo, Xiaoling, et al.. (2025). Multifunctional nanoplatform for tumor chemodynamic and self-amplified photodynamic cascade therapy. Journal of Advanced Research. 79. 721–736.

Han, Chuangye, et al.. (2024). Advancements in programmed cell death research in antitumor therapy: a comprehensive overview. APOPTOSIS. 30(1-2). 401–421. 7 indexed citations

Zeng, Ming, et al.. (2024). Stereotactic Radiotherapy vs. Whole Brain Radiation Therapy in EGFR Mutated NSCLC: Results and Reflections from the Prematurely Closed Phase III HYBRID Trial. International Journal of Radiation Oncology*Biology*Physics. 120(2). e294–e294.

Fang, Dalang, Shuqi Zhao, Tingdong Yu, et al.. (2022). Down regulated oncogene KIF2C inhibits growth, invasion, and metastasis of hepatocellular carcinoma through the Ras/MAPK signaling pathway and epithelial-to-mesenchymal transition. Annals of Translational Medicine. 10(3). 151–151. 24 indexed citations

Liang, Rong, et al.. (2021). Ethacrynic Acid Enhances the Antitumor Effects of Afatinib in EGFR/T790M-Mutated NSCLC by Inhibiting WNT/Beta-Catenin Pathway Activation. Disease Markers. 2021. 1–17. 7 indexed citations

Liang, Rong, Jinyan Zhang, Zhihui Liu, et al.. (2021). Mechanism and Molecular Network of RBM8A-Mediated Regulation of Oxaliplatin Resistance in Hepatocellular Carcinoma. Frontiers in Oncology. 10. 585452–585452. 15 indexed citations

Zhong, Huage, et al.. (2020). ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma. BioMed Research International. 2020(1). 3575038–3575038. 9 indexed citations

10.

Tang, Yanping, et al.. (2020). Global transcriptomic study of circRNAs expression profile in sorafenib resistant hepatocellular carcinoma cells. Journal of Cancer. 11(10). 2993–3001. 27 indexed citations

11.

Takai, Atsushi, Hien Dang, Naoki Oishi, et al.. (2019). Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma. Cancer Research. 79(9). 2379–2391. 23 indexed citations

12.

Wang, Ying, Xiaoling Luo, Siyu Liu, et al.. (2017). Apoptotic Protease Activating Factor‐1 Inhibitor Mitigates Myocardial Ischemia Injury via Disturbing Procaspase‐9 Recruitment by Apaf‐1. Oxidative Medicine and Cellular Longevity. 2017(1). 9747296–9747296. 8 indexed citations

13.

Ye, Jiazhou, Shumei Yan, Chunling Yuan, et al.. (2017). GP73 level determines chemotherapeutic resistance in human hepatocellular carcinoma cells. Journal of Cancer. 9(2). 415–423. 19 indexed citations

14.

Wang, Yuhuan, et al.. (2017). Synergy of purine-scaffold TLR7 agonist with doxorubicin on systemic inhibition of lymphoma in mouse model. Journal of Cancer. 8(16). 3183–3189. 10 indexed citations

15.

Cao, Jingsong, et al.. (2016). Influence of autologous dendritic cells on cytokine-induced killer cell proliferation, cell phenotype and antitumor activity in vitro. Oncology Letters. 12(3). 2033–2037. 55 indexed citations

16.

Pan, Li‐Long, Qiuyang Zhang, Xiaoling Luo, et al.. (2016). (7R,8S)-9-Acetyl-dehydrodiconiferyl alcohol inhibits inflammation and migration in lipopolysaccharide-stimulated macrophages. Phytomedicine. 23(5). 541–549. 14 indexed citations

17.

Luo, Xiaoling, Siyu Liu, Lijun Wang, et al.. (2016). A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia. European Journal of Pharmacology. 774. 135–143. 27 indexed citations

18.

Cao, Jingsong, Weiguo Yin, Cong Chen, & Xiaoling Luo. (2014). [Effects of autologous plasma and gentamicin on immunophenotype and viability of cytokine-induced killer cells].. PubMed. 30(9). 906–8. 2 indexed citations

19.

Yang, Wanzhang, Yun Zhang, Fang Wu, et al.. (2010). Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. Journal of Translational Medicine. 8(1). 75–75. 50 indexed citations

20.

Su, Jianjia, Chun Yang, Yuan Li, et al.. (1999). Expression of ras gene in experimental hepatocarcinogenesis in tree shrews. Chinese Journal of Cancer Research. 11(1). 23–25. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact